These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1988722)

  • 1. Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
    Qvist HL; Fosså SD; Ous S; Høie J; Stenwig AE; Giercksky KE
    J Urol; 1991 Feb; 145(2):300-2; discussion 302-3. PubMed ID: 1988722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
    Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
    Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.
    Beck SD; Foster RS; Bihrle R; Ulbright T; Koch MO; Wahle GR; Einhorn LH; Donohue JP
    J Urol; 2002 Oct; 168(4 Pt 1):1402-4. PubMed ID: 12352402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
    Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
    Herr HW; Toner GC; Geller NL; Bosl GJ
    Eur Urol; 1991; 19(1):1-5. PubMed ID: 1848821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.
    Fosså SD; Ous S; Lien HH; Stenwig AE
    J Urol; 1989 Mar; 141(3):557-9. PubMed ID: 2918591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report].
    Matsuzaki M; Nakano M; Komatsu H; Ohashi K
    Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
    Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.
    Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J
    J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
    Steyerberg EW; Keizer HJ; Messemer JE; Toner GC; Schraffordt Koops H; Fosså SD; Gerl A; Sleijfer DT; Donohue JP; Habbema JD
    Cancer; 1997 Jan; 79(2):345-55. PubMed ID: 9010108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?
    Herr HW
    Br J Urol; 1997 Oct; 80(4):653-7. PubMed ID: 9352708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extent of surgery after chemotherapy for advanced germ cell tumors.
    Freiha FS; Shortliffe LD; Rouse RV; Mark JB; Hannigan JF; Aston D; Spaulding JT; Williams RD; Torti FM
    J Urol; 1984 Nov; 132(5):915-7. PubMed ID: 6208386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
    Culine S
    Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
    [No Abstract]   [Full Text] [Related]  

  • 20. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.
    Steyerberg EW; Gerl A; Fossá SD; Sleijfer DT; de Wit R; Kirkels WJ; Schmeller N; Clemm C; Habbema JD; Keizer HJ
    J Clin Oncol; 1998 Jan; 16(1):269-74. PubMed ID: 9440752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.